|
Delayed
Nasdaq
06:00:00 28/04/26 am AEST
|
5-day change | 1st Jan Change | ||
| 115.07 USD | +0.03% |
|
-.--% | +76.49% |
| 08/05 | Gilead Sciences Expects Loss This Year on Acquired R&D Expenses | DJ |
| 08/05 | Gilead raises 2026 sales forecast, flags profit hit from acquisitions | RE |
Published on 12/07/2025 at 02:50 pm AEDT - Modified on 12/07/2025 at 10:20 pm AEDT
Presenter Speech
Rami Elghandour (Executives)
Good evening. Welcome. I'm Rami Elghandour, I'm the Chairman and CEO of Arcellx. It is my pleasure to welcome you this evening to our Investor Relations
B
Select your edition
All financial news and data tailored to specific country editions
